XPOVIO® Receives Reimbursement Approval in South Korea for a Second Multiple Myeloma Indication
- XPOVIO® is the first XPO1 inhibitor approved for reimbursement by South Korea's National Health Insurance Service (NHIS) for the treatment of adult patients with multiple myeloma (MM). - In South Korea, XPOVIO® has been approved for three...
Cynosure Lutronic bolsters its strength in APAC -- The world's fastest-growing medical aesthetics device region, with dual regulatory approvals for the Clarity II™ in China and Japan, February 2026
SINGAPORE, Feb. 27, 2026 /PRNewswire/ -- Cynosure Lutronic, a global leader in energy-based medical aesthetic devices, announced today that Clarity II, its dual-wavelength long-pulse laser platform, has received regulatory approval in China and...
DIFF Biotech's Innovative Nasal Spray Influenza Vaccine Receives Clinical Trial Approval, Introducing a New Attenuation Pathway
HANGZHOU, China, Feb. 9, 2026 /PRNewswire/ -- Zhejiang Difference Biological Technology Co., Ltd. (DIFF Biotech) announced that its proprietary nasal spray influenza attenuated live vaccine, DIFF-flu, has recently received clinical trial approval as...
Insilico Medicine Receives USD 5million Milestone Payment from Menarini Group Following First-in-Human (FIH) Achievement for MEN2501
Followed by the development and regulatory milestone payment of USD 3 million in July 2025, Insilico received an additional milestone payment of USD 5 million from Menarini Group after first-in-patient dosing in a Phase 1 trial of MEN2501, highly...
Frost & Sullivan: Didcom receives the 2025 Mexican Intelligent Mobility & Connected Truck Telematics Customer Value Leadership Recognition for Advancing Fleet-Centric Innovation
Didcom is recognized for driving customer acquisition and operational transformation through engineering excellence and intelligent mobility solutions. SAN ANTONIO, Feb. 3, 2026 /PRNewswire/ -- Frost & Sullivan is pleased to announce that Didcom...
Samsung Biologics receives EcoVadis Platinum, the highest sustainability rating
Ranked in the top one percent among more than 150,000 companies assessed globally Recognized for strengthened sustainability management across all four assessment categories INCHEON, South Korea, Jan. 28, 2026 /PRNewswire/ -- Samsung Biologics (KRX:...
AIM Vaccine's 20-Valent Pneumococcal Conjugate Vaccine Receives Clinical Approval, Upgraded Iterative Major Product Expected to Seize Domestic Opportunities
HONG KONG, Jan. 20, 2026 /PRNewswire/ -- AIM Vaccine (06660.HK), a leading domestic vaccine company, announced on January 19 that it has developed an optimized upgraded version of its iterative 20-valent pneumococcal conjugate vaccine, which has...
iotaMotion Receives FDA Clearance for Expanded Pediatric Use of iotaSOFT® Robotic-Assisted Cochlear Implant Insertion System
ST. PAUL, Minn., Jan. 14, 2026 /PRNewswire/ -- iotaMotion, Inc., creator of iotaSOFT®, the first and only FDA cleared robotic-assisted cochlear implant insertion system, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for...
Aeris Receives Frost & Sullivan's 2025 Global Competitive Strategy Leadership Recognition for Advancing Next-Generation IoT Connectivity Management
Delivering global market leadership through IoT connectivity innovation, ecosystem scale, and customer-centric execution SAN ANTONIO, Jan. 13, 2026 /PRNewswire/ -- Frost & Sullivan is pleased to announce that Aeris, a global leader in cellular...
NETSCOUT Receives Frost & Sullivan's 2025 Global Company of the Year Recognition for Network Monitoring Leadership
The company is acknowledged for its market leadership, innovation, and customer-centric execution in network monitoring, performance assurance, and real-time visibility. SAN ANTONIO, Jan. 13, 2026 /PRNewswire/ -- Frost & Sullivan is pleased to...